Abstract:BackgroundCancer is the second leading cause of death in the United States, exceeded only by heart disease. Extant cancer survival analyses have primarily focused on individual-level factors due to limited data availability from a single data source. There is a need to integrate data from different sources to simultaneously study as much risk factors as possible. Thus, we proposed an ontology-based approach to integrate heterogeneous datasets addressing key data integration challenges.MethodsFollowing best practices in ontology engineering, we created the Ontology for Cancer Research Variables (OCRV) adapting existing semantic resources such as the National Cancer Institute (NCI) Thesaurus. Using the global-as-view data integration approach, we created mapping axioms to link the data elements in different sources to OCRV. Implemented upon the Ontop platform, we built a data integration pipeline to query, extract, and transform data in relational databases using semantic queries into a pooled dataset according to the downstream multi-level Integrative Data Analysis (IDA) needs.ResultsBased on our use cases in the cancer survival IDA, we created tailored ontological structures in OCRV to facilitate the data integration tasks. Specifically, we created a flexible framework addressing key integration challenges: (1) using a shared, controlled vocabulary to make data understandable to both human and computers, (2) explicitly modeling the semantic relationships makes it possible to compute and reason with the data, (3) linking patients to contextual and environmental factors through geographic variables, (4) being able to document the data manipulation and integration processes clearly in the ontologies.ConclusionsUsing an ontology-based data integration approach not only standardizes the definitions of data variables through a common, controlled vocabulary, but also makes the semantic relationships among variables from different sources explicit and clear to all users of the same datasets. Such an approach resolves the ambiguity in variable selection, extraction and integration processes and thus improve reproducibility of the IDA.

Ioda: an Integrated Tool for Analysis of Cancer Pathway Consistency from Heterogeneous Multi-Omics Data

IOAT: an interactive tool for statistical analysis of omics data and clinical data

Identification of Cancer Dysfunctional Subpathways by Integrating DNA Methylation, Copy Number Variation, and Gene-Expression Data

IOBR: Multi-Omics Immuno-Oncology Biological Research to Decode Tumor Microenvironment and Signatures

An Integrated Pipeline For Tcga Data Analysis

Cancer DEIso: An integrative analysis platform for investigating differentially expressed gene-level and isoform-level human cancer markers

An ontology-guided semantic data integration framework to support integrative data analysis of cancer survival

Integrative analysis of pathological images and multi-dimensional genomic data for early-stage cancer prognosis.

ICan: an Integrated Co-Alteration Network to Identify Ovarian Cancer-Related Genes.

CAMOIP: a web server for comprehensive analysis on multi-omics of immunotherapy in pan-cancer

IOBR2: Multidimensional Decoding Tumor Microenvironment for Immuno-Oncology Research

Multi-omics integration with weighted affinity and self-diffusion applied for cancer subtypes identification

Identification of Cancer Development Related Pathways Based on Co-Expression Analyses

Integrate Any Omics: Towards genome-wide data integration for patient stratification

An Integrated Framework for Identifying Mutated Driver Pathway and Cancer Progression.

ICM: a Web Server for Integrated Clustering of Multi-Dimensional Biomedical Data.

An Integrated Tool for Multi-Dimensional Cancer Research Utilizing Clinical Proteomic Tumor Analysis Consortium Data

A novel dysregulated pathway-identification analysis based on global influence of within-pathway effects and crosstalk between pathways.

Pathway Bridge Based Multiobjective Optimization Approach for Lurking Pathway Prediction.

ioSearch: An approach for identifying interacting multiomics biomarkers using a novel algorithm with application on breast cancer data sets

Simultaneous Interrogation of Cancer Omics to Identify Subtypes with Significant Clinical Differences